Bank of America’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-156
Closed -$5.93K 8499
2024
Q1
$5.93K Buy
+156
New +$5.79K ﹤0.01% 6974
2023
Q3
Sell
-354
Closed -$12.7K 8011
2023
Q2
$12.7K Hold
354
﹤0.01% 6808
2023
Q1
$11.8K Sell
354
-793
-69% -$27.6K ﹤0.01% 6887
2022
Q4
$38.6K Sell
1,147
-354
-24% -$11.9K ﹤0.01% 6561
2022
Q3
$52K Sell
1,501
-23
-2% -$836 ﹤0.01% 6661
2022
Q2
$49K Buy
1,524
+23
+2% +$768 ﹤0.01% 6840
2022
Q1
$59K Hold
1,501
﹤0.01% 7107
2021
Q4
$71K Buy
+1,501
New +$77.4K ﹤0.01% 7054

Other funds holding BTEC

Bank of America's BTEC Position: Q2 2024 in Review

Bank of America sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q2 2024, closing a stake of 156 shares — an estimated $5.93K sold.

Bank of America first reported a position in BTEC in Q4 2021 and held it in 8 quarters. The position peaked at $71K in Q4 2021. 20 funds tracked by Wall St. Rank hold BTEC as of Q2 2024.

  • Bank of America reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q2 2024 after selling out during the quarter.
  • Bank of America sold 156 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q2 2024, an estimated $5.93K.
  • Bank of America first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q4 2021 and held it in 8 quarters.
  • Bank of America's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $71K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.